猪肺炎支原体灭活疫苗的初步应用  

The Clinical Application of Swine Mycoplasma Hyopneumoniae Inactivated Vaccines

作　　者：刘涛[1,2] 张德宝[1,2] 高晓磊[1,2] 朱秀同[1,2] 郁宏伟[1,2] 徐步晗 

机构地区：[1]瑞普(保定)生物药业有限公司,河北保定071000 [2]河北省兽医生物技术工程技术研究中心,河北保定071000

出　　处：《中国动物保健》2016年第12期87-88,共2页China Animal Health

基　　金：保定市科技计划项目(16J01)

摘　　要：对公司连续制备的3批次猪肺炎支原体灭活疫苗进行了实验室检验(安全性、效力性)和初步临床应用(安全性、效力性)。结果表明该产品对免疫猪安全,并且可使免疫猪肺炎病变减少率达到80%以上,临床应用免疫效果明显。In this study, we checked 3 lasting batches of swine Mycoplasma hyopneumoniae inactivated vaccines in the laboratory （ security and effective ） , and the immune effect was verified by preliminary clinical application. The results showed that the vaccine was safe to swine, and the immune protective rate was over 80%. Totally the clinical immune effect was obvious.

关 键 词：猪肺炎支原体 实验室检验 临床应用 

分 类 号：S858.28[农业科学—临床兽医学]